MRK vs TECH
By Alex · Tickerpine
Merck & Co., Inc. vs Bio-Techne Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | TECH |
|---|---|---|
| Price | $145.27 | $72.55 |
| Market cap | $358.41B | $11.38B |
| P/E ratio | 117.2 | 62.5 |
| ROE | 6.96% | 9.03% |
| Profit margin | 4.77% | 14.97% |
| Revenue growth | 5.10% | 1.30% |
| Dividend yield | 2.34% | 0.44% |
| Beta | 0.22 | 1.29 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs TECH in plain English
- MRK is the bigger company — about 31.5× the market cap of TECH.
- TECH is cheaper on earnings (P/E 62.5 vs 117.2).
- TECH earns a higher return on equity (9% vs 7%).
- MRK is growing revenue faster (5% vs 1%).
- MRK has the higher dividend yield (2.34% vs 0.44%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
TECH return calculator
See what $1,000 in Bio-Techne Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.